Nanogen, deCode Genetics enter into supply and license agreement

April 19, 2005 — Nanogen Inc. (Nasdaq: NGEN) announced it entered into a supply and license agreement with deCode Genetics to provide a new genomics assay for single nucleotide polymorphism (SNP) discovery, validation and screening.

The assay incorporates a range of Nanogen’s products, including the Eclipse Dark Quencher, new DNA linker technology, modified bases and novel fluorescent dyes, and allows rapid SNP analysis on a large number of patient samples.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.